Category: Optical / Ophthalmic

Abbott wins FDA nod for intraocular lens

March 10, 2010 by MassDevice staff

Abbott (NYSE:ABT) won PMA clearance from the Food & Drug Administration for its TECNIS Multifocal 1-Piece intraocular lens, which the federal watchdog approved for treating cataract patients.

The Abbott Park, Ill.-based medical products conglomerate said the lens, which is implanted in the eye after the removal of the cataract-occluded natural lens, corrects presbyopia. That's a condition in older patients the prevents the eye from adjusting its focal length.

Optos' 2009 sales dip 4 percent as it slides into the red after $6.3 million restructuring

January 26, 2010 by MassDevice staff

Optos plc (LSE:OPTS) posted sales of $97.2 million during fiscal 2009, down 3.6 percent compared with $100.8 million during fiscal 2008, and dipped into the red after spending more than $6.3 million in a soup-to-nuts restructuring.

The British retinal imaging firm, which has operations in Marlborough, Mass., posted a net loss of $4.3 million, or 6.1 cents per diluted share, compared with net profits of $4.6 million, or 6.6 cents per diluted share, during the prior year.

Optos plunges into the red for fiscal 2009

December 2, 2009 by MassDevice staff

Sales for Optos plc (LSE:OPTS) slid 3.6 percent during fiscal 2009, to $97.2 million, but its strategy to boost pay-per-patient revenues continued to gain traction even as it posted a net loss for the year.

The British retinal imaging firm, which has operations in Marlborough, Mass., said its pay-per-patient revenues for the fiscal year ended Sept. 30 rose 2 percent to $93.5 million, compared with $91.7 million during the same period last year, as it developed its strategy to shift from large capital equipment sales.

Iridex posts Q3 profits despite revenue slide

November 13, 2009 by MassDevice staff

Iridex Corp. (IRIX) posted third-quarter sales of $10.4 million for the three months ended Oct. 3, down 13.2 percent compared with $12 million during the same period last year. The Mountian View, Calif.-based laser medical device maker swung to profit for the quarter, with net income fell of $646,000 compared with a net loss of $249,000 during Q3 2008:

Press Release

IRIDEX Reports Third Quarter 2009 Financial Results

Third Consecutive Profitable Quarter

Staar Surgical's Q3 losses narrow on flat sales

November 4, 2009 by MassDevice staff

Staar Surgical Co. posted net losses of $2 million on sales of $18.1 million during the third quarter:

Press Release

STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter

Largest Amount of Cash from Operating Activities in More Than Six Years

Domestic Operating Expenses Down and Gross Margins Up

Global Visian ICL(R) Sales Increase Five Percent

Global IOL Sales Grow Seven Percent

CAST Project Surpasses 300 Eyes; nanoFLEX(TM) Marketing to Increase in U.S.

I-Therapeutix changes its name to Ocular Therapeutix

September 24, 2009 by MassDevice staff

I-Therapeutix Inc. changed its name to Ocular Therapeutix Inc.

President and CEO Amar Sawhney said (PDF) the change is aimed at better reflecting the company's mission.

Ocular Therapeutix is seeking approval from the Food & Drug Administration for its I-Zip ocular bandage, which is applied as a liquid but morphs into a soft, protective barrier which then breaks down into tears when the therapy is complete.